137 related articles for article (PubMed ID: 31442647)
21. Serum melatonin levels in survivor and non-survivor patients with traumatic brain injury.
Lorente L; Martín MM; Abreu-González P; Pérez-Cejas A; Ramos L; Argueso M; Solé-Violán J; Cáceres JJ; Jiménez A; García-Marín V
BMC Neurol; 2017 Jul; 17(1):138. PubMed ID: 28724361
[TBL] [Abstract][Full Text] [Related]
22. Total antioxidant capacity is associated with mortality of patients with severe traumatic brain injury.
Lorente L; Martín MM; Almeida T; Abreu-González P; Ramos L; Argueso M; Riaño-Ruiz M; Solé-Violán J; Jiménez A
BMC Neurol; 2015 Jul; 15():115. PubMed ID: 26205136
[TBL] [Abstract][Full Text] [Related]
23. High Serum Caspase-Cleaved Cytokeratin-18 Levels and Mortality of Traumatic Brain Injury Patients.
Lorente L; Martín MM; González-Rivero AF; Pérez-Cejas A; Argueso M; Ramos L; Solé-Violán J; Cáceres JJ; Jiménez A; García-Marín V
Brain Sci; 2019 Oct; 9(10):. PubMed ID: 31658711
[TBL] [Abstract][Full Text] [Related]
24. Serum biomarkers as predictors of long-term outcome in severe traumatic brain injury: analysis from a randomized placebo-controlled Phase II clinical trial.
Raheja A; Sinha S; Samson N; Bhoi S; Subramanian A; Sharma P; Sharma BS
J Neurosurg; 2016 Sep; 125(3):631-41. PubMed ID: 26722854
[TBL] [Abstract][Full Text] [Related]
25. Serum caspase-3 levels during the first week of traumatic brain injury.
Lorente L; Martín MM; Pérez-Cejas A; González-Rivero AF; Argueso M; Ramos L; Solé-Violán J; Cáceres JJ; Jiménez A; García-Marín V
Med Intensiva (Engl Ed); 2021 Apr; 45(3):131-137. PubMed ID: 31677852
[TBL] [Abstract][Full Text] [Related]
26. High serum substance P levels and mortality after malignant middle cerebral artery infarction.
Lorente L; Martín MM; Pérez-Cejas A; González-Rivero AF; Argueso M; Ramos L; Solé-Violán J; Cáceres JJ; Jiménez A; García-Marín V
J Crit Care; 2020 Jun; 57():1-4. PubMed ID: 31991332
[TBL] [Abstract][Full Text] [Related]
27. Determination of serum tissue kallikrein levels after traumatic brain injury.
Huang JJ; Qiu SZ; Zheng GR; Chen B; Shen J; Yin HM; Mao W
Clin Chim Acta; 2019 Dec; 499():93-97. PubMed ID: 31499021
[TBL] [Abstract][Full Text] [Related]
28. The 90-day prognostic value of serum cyclophilin A in traumatic brain injury.
Jin HH; Mao TM; Bai ZQ; Chen Y; Ji HL; Jin Y
Clin Chim Acta; 2018 Sep; 484():258-264. PubMed ID: 29885319
[TBL] [Abstract][Full Text] [Related]
29. Serum lipocalin-2 concentrations and mortality of severe traumatic brain injury.
Shen LJ; Zhou J; Guo M; Yang CS; Xu QC; Lv QW; Yang SB; Huang HB
Clin Chim Acta; 2017 Nov; 474():130-135. PubMed ID: 28943289
[TBL] [Abstract][Full Text] [Related]
30. RANTES levels in peripheral blood, CSF and contused brain tissue as a marker for outcome in traumatic brain injury (TBI) patients.
Albert V; Subramanian A; Agrawal D; Bhoi SK; Pallavi P; Mukhopadhayay AK
BMC Res Notes; 2017 Mar; 10(1):139. PubMed ID: 28340601
[TBL] [Abstract][Full Text] [Related]
31. Association between serum malondialdehyde levels and mortality in patients with severe brain trauma injury.
Lorente L; Martín MM; Abreu-González P; Ramos L; Argueso M; Cáceres JJ; Solé-Violán J; Lorenzo JM; Molina I; Jiménez A
J Neurotrauma; 2015 Jan; 32(1):1-6. PubMed ID: 25054973
[TBL] [Abstract][Full Text] [Related]
32. Association between serum concentrations of anti-apoptotic B-cell lymphoma-2 protein and traumatic brain injury mortality.
Lorente L; Martín MM; González-Rivero AF; Pérez-Cejas A; Ramos-Gómez L; Solé-Violán J; Cáceres JJ; Ferrer-Moure C; Jiménez A
Expert Rev Mol Diagn; 2022 Jan; 22(1):125-129. PubMed ID: 34878357
[TBL] [Abstract][Full Text] [Related]
33. Serum caspase-3 levels and mortality are associated in patients with severe traumatic brain injury.
Lorente L; Martín MM; Argueso M; Ramos L; Solé-Violán J; Riaño-Ruiz M; Jiménez A; Borreguero-León JM
BMC Neurol; 2015 Nov; 15():228. PubMed ID: 26545730
[TBL] [Abstract][Full Text] [Related]
34. Higher plasma C-type lectin-like receptor 2 concentrations for prediction of higher risk of 30-day mortality in isolated severe blunt traumatic brain injury.
Guo M; Zhang H; Lv QW; Huang HB; Shen LJ
Clin Chim Acta; 2019 Sep; 496():1-6. PubMed ID: 31202718
[TBL] [Abstract][Full Text] [Related]
35. A prospective study on serum secreted protein acidic and rich in cysteine-like 1 as a prognostic marker for severe traumatic brain injury.
Huang HB; Yang SB; Shen LJ; Lv QW; Guo M; Zhou J; Li Z; Yang CS; Wang LY; Zhang H
Clin Chim Acta; 2019 Apr; 491():19-23. PubMed ID: 30639238
[TBL] [Abstract][Full Text] [Related]
36. Plasma brain-derived neurotrophic factor levels after severe traumatic brain injury.
Simon D; Nascimento RI; Filho EM; Bencke J; Regner A
Brain Inj; 2016; 30(1):23-8. PubMed ID: 26555864
[TBL] [Abstract][Full Text] [Related]
37. Plasma matrix metalloproteinase-9 levels predict intensive care unit mortality early after severe traumatic brain injury.
Simon D; Evaldt J; Nabinger DD; Fontana MF; Klein MG; do Amaral Gomes J; Regner A
Brain Inj; 2017; 31(3):390-395. PubMed ID: 28156136
[TBL] [Abstract][Full Text] [Related]
38. Association of Lectin Pathway Protein Levels and Genetic Variants Early after Injury with Outcomes after Severe Traumatic Brain Injury: A Prospective Cohort Study.
Osthoff M; Walder B; Delhumeau C; Trendelenburg M; Turck N
J Neurotrauma; 2017 Sep; 34(17):2560-2566. PubMed ID: 28482760
[TBL] [Abstract][Full Text] [Related]
39. Bio-Shock Index: Proposal and Rationale for a New Predictive Tool for In-Hospital Mortality in Patients with Traumatic Brain Injury.
El-Menyar A; Asim M; Ramzee AF; Nabir S; Ahmed MN; Al-Thani A; Al-Abdulmalek A; Al-Thani H
World Neurosurg; 2019 Dec; 132():e169-e177. PubMed ID: 31505291
[TBL] [Abstract][Full Text] [Related]
40. Serum thioredoxin and in-hospital major adverse events after traumatic brain injury.
Dong XQ; Yu WH; Zhang ZY; Yang DB; Du Q; Wang H; Shen YF; Jiang L; Che ZH; Zhu Q
Clin Chim Acta; 2017 Jun; 469():75-80. PubMed ID: 28347674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
